NCT06807372 2026-03-10
Validation of a Model for Predicting Duodenal Stump Leakage After Gastrectomy
First Affiliated Hospital of Zhejiang University
Active not recruiting
Clinical Trials
70 trialsNCT07448493 2026-03-04
GASTROBRAIN
Blokhin's Russian Cancer Research Center
Active not recruiting
NCT07224035 2026-02-17
Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1
University of Miami
Phase 4 Active not recruiting
NCT07224048 2026-02-17
Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2
University of Miami
Phase 4 Active not recruiting
NCT03399110 2026-01-27
XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)
Fudan University
Phase 3 Active not recruiting
NCT03257163 2026-01-20
Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer
Rutgers, The State University of New Jersey
Phase 2 Active not recruiting
NCT00582647 2026-01-15
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT05203627 2026-01-05
Telehealth for the Self-Management of Dietary Quality of Life in Patients After Stomach Cancer Surgery
City of Hope Medical Center
Phase NA Active not recruiting
NCT06967571 2026-01-02
REJOY
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Active not recruiting
NCT07312500 2025-12-31
Fecal DNA Methylation and Helicobacter Pylori SNPs Tests for Gastric Cancer
Fudan University
Active not recruiting
NCT05075993 2025-12-26
Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT04209686 2025-12-03
Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Active not recruiting
NCT05025826 2025-12-02
PROPERTY
Nantes University Hospital
Phase NA Active not recruiting
NCT07257575 2025-12-02
A Randomized Controlled Study of Serplulimab Combined With Chemotherapy for Locally Advanced Gastric Adenocarcinoma
Guangdong Provincial People's Hospital
Phase 2 Active not recruiting
NCT07180966 2025-09-18
SAH
Ruijin Hospital
Active not recruiting
NCT07147452 2025-08-29
SLN_GC_SPIO
Hospital del SAS de Jerez
Active not recruiting
NCT05029869 2025-08-13
Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description
University Medical Center Ho Chi Minh City (UMC)
Active not recruiting
NCT04147494 2025-08-12
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT05038254 2025-08-12
Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT05057013 2025-08-11
A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
Cancer Research UK
Phase 1/2 Active not recruiting
NCT06384417 2025-08-08
Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2
Milton S. Hershey Medical Center
Phase NA Active not recruiting
NCT07113340 2025-08-08
Carina™ Surgical Platform for Minimal Radical Gastrectomy
The Affiliated Hospital of Qingdao University
Phase NA Active not recruiting
NCT03421288 2025-07-25
DANTE
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Active not recruiting
NCT07080879 2025-07-23
The Advantages and Disadvantages of Linear Anastomat and Tubular Anastomat in Radical Gastrectomy of Distal Gastric Cancer
Xiangya Hospital of Central South University
Phase NA Active not recruiting
NCT06243757 2025-07-22
A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT03348150 2025-07-17
PERISCOPEII
The Netherlands Cancer Institute
Phase 3 Active not recruiting
NCT05379972 2025-07-16
Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers
University of Colorado, Denver
Phase 2 Active not recruiting
NCT06427252 2025-07-16
The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Active not recruiting
NCT06893133 2025-06-25
MRD-GC
Peking University
Active not recruiting
NCT04384757 2025-06-15
Comparison of Open and Laparoscopic Distal Gastrectomy for T4a Gastric Cancer
University Medical Center Ho Chi Minh City (UMC)
Phase NA Active not recruiting
NCT04817826 2025-06-10
INFINITY
Gruppo Oncologico del Nord-Ovest
Phase 2 Active not recruiting
NCT06997302 2025-05-30
A Study on the Impact of Intelligent Nutrition Management on Clinical Outcomes in Chemotherapy Patients With Gastrointestinal Malignancies
Tianjin Medical University Cancer Institute and Hospital
Phase NA Active not recruiting
NCT06940921 2025-04-27
SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal Metastases
First Affiliated Hospital of Chongqing Medical University
Phase 1/2 Active not recruiting
NCT05782465 2025-04-18
Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study)
National University Hospital, Singapore
Active not recruiting
NCT04166721 2025-04-06
WaKING: Wnt and checKpoint INhibition in Gastric Cancer
Royal Marsden NHS Foundation Trust
Phase 1/2 Active not recruiting
NCT05076279 2025-03-19
Safety and Efficacy of Single or Reduced Ports Laparoscopic Gastrectomy for Advanced Gastric Cancer (SPACE-01)
Seoul National University Bundang Hospital
Phase NA Active not recruiting
NCT06877910 2025-03-14
Deciphering the Molecular Traits of Non-canonical Responders to Advance Personalized Therapy in Gastric Cancer
Regina Elena Cancer Institute
Active not recruiting
NCT03044613 2025-03-06
Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Active not recruiting
NCT06856382 2025-03-04
The Association Between Microplastics and Macrogenomics and Metabolomics in Gastric Cancer
First Affiliated Hospital of Chongqing Medical University
Active not recruiting
NCT06854146 2025-03-03
The Effect of Environmental Factors on Gastric Cancer Based on Macrogenome
First Affiliated Hospital of Chongqing Medical University
Active not recruiting
NCT06790238 2025-01-24
POWER 4 + 3
Grupo Español de Rehabilitación Multimodal
Active not recruiting
NCT03368963 2025-01-07
TAS102 in Combination With NAL-IRI in Advanced GI Cancers
Emory University
Phase 1/2 Active not recruiting
NCT06157216 2025-01-07
Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer
Qilu Hospital of Shandong University
Phase NA Active not recruiting
NCT04593615 2024-12-30
CLASS-11
Fujian Medical University
Phase NA Active not recruiting
NCT05352802 2024-12-13
Multimodal Prehabilitation To Improve The Clinical Outcomes Of Frail Elderly Patients With Gastric Cancer
The Affiliated Hospital of Qingdao University
Phase NA Active not recruiting
NCT06301464 2024-11-29
Pepsinogen II and Helicobacter Pylori Test in Gastric Cancer
Seoul National University Bundang Hospital
Active not recruiting
NCT04745988 2024-11-15
An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib with Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients with Gastric Cancer
National Cancer Center Hospital East
Phase 2 Active not recruiting
NCT06680362 2024-11-08
The Influence of Splenic Artery Characteristics in Gastric Cancer Surgery
Xijing Hospital of Digestive Diseases
Active not recruiting
NCT03979131 2024-11-07
MONEO
Vall d'Hebron Institute of Oncology
Phase 2 Active not recruiting
NCT06641700 2024-10-16
Predictive Value of Air Pollution and Metabolomics for Gastric Cancer.
First Affiliated Hospital of Chongqing Medical University
Active not recruiting